Skip to content

Establishment of a LVAD Destination Program in a Swiss Non Cardiac Transplant University Hospital

Establishment of a LVAD Destination Program in a Swiss Non Cardiac Transplant University Hospital: 5 Year Experience

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04263012
Enrollment
20
Registered
2020-02-10
Start date
2019-12-01
Completion date
2019-12-31
Last updated
2020-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart Implant Complication

Keywords

left ventricular assist device (LVAD), heart, implant, artificial

Brief summary

The goal of this study is to demonstrate the challenges and the effort to set up an artificial heart program as well as to report about the follow-up treatment and the mortality rate

Interventions

assess mortality rate, rehospitalization and survival rate of patients after receiving an artificial heart implant

Sponsors

University Hospital, Basel, Switzerland
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL

Inclusion criteria

* Patients who received an LVAD implant

Exclusion criteria

* not enough data collected * stated will of the Patient, that his data can not be used

Design outcomes

Primary

MeasureTime frameDescription
30 days mortality30 days after surgerymortality rate 30 days after receiving the LVAD implant
rehospitalization ratebetween day of surgery and 31.12.2019rehospitalization rate of patients after receiving the LVAD implant

Secondary

MeasureTime frameDescription
survival ratebetween day of surgery and 31.12.2019survival rate of patients after receiving the LVAD implant (Kaplan-Meier curve)

Countries

Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 15, 2026